Intelligence IAMay 15, 2026Intelligence IA
Article
Citius Oncology reported positive progress in the launch of LYMPHIR®.
First-half fiscal 2026 revenue reached $5.6 million, with broad payer coverage already established.
Redaction Data Cube AISource: PR Newswire
01
Brief source
Citius Oncology reported positive progress in the launch of LYMPHIR®. First-half fiscal 2026 revenue reached $5.6 million, with broad payer coverage already established.